Bellerophon Therapeutics (BLPH) Q3 2023 Earnings

14NovConfirmed
Nov 22
Q1 2023
Q2 2023
Q3 2023
-0.58
-0.44
-0.3
-0.16

Details

Expected EPS
-0.44
Actual EPS
-0.16
Surprise EPS
0.28
Surprise Percent
+63.64%

Description

Bellerophon Therapeutics (BLPH) has reported earnings of -0.16 per share for Q3 2023.

0 Comments

Share your thoughts